Literature DB >> 3081522

Evaluation of gastrointestinal toxicity following cytostatic chemotherapy.

J M Smit, N H Mulder, D T Sleijfer, J G Bouman, W Veeger.   

Abstract

A number of clinical and chemical parameters related to the gastrointestinal tract in patients treated with intensive chemotherapy for disseminated malignant melanoma were evaluated in order to find quantitative indicators for gastrointestinal toxicity and to investigate the cause of diarrhea after chemotherapy. In 11 patients 17 courses of polychemotherapy with bleomycin, DTIC, vindesine, and actinomycin D were administered, while the patients received complete liquid enteral nutrition. As clinical parameters for toxicity the diarrhea grading system according to the WHO criteria and the daily fecal consistency were used. Furthermore, in the feces Na+, K+, and Cl- (mmol/24 h), Na+/K+ ratio, dry and wet weight (g/24 h), lactate and bile acids (mmol/24 h), fat (g/24 h), pH, and osmolarity were determined. Both clinical parameters were closely correlated. The most important effects of the chemotherapy on the chemical parameters were an increased fecal fluid, K+, and fat excretion. The fecal wet weight and K+ excretion showed a high correlation with the two clinical parameters for gastrointestinal toxicity. We conclude that mucosal injury resulting from chemotherapy probably leads to increased small intestinal fluid and electrolyte secretion inducing diarrhea and that fecal wet weight and K+ excretion are probably the best quantitative indicators for gastrointestincal toxicity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081522     DOI: 10.1007/bf00402778

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  9 in total

1.  QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS.

Authors:  S M GRUNDY; E H AHRENS; T A MIETTINEN
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

2.  Diarrhoea caused by deficiency of sugar splitting enzymes. I.

Authors:  H A WEIJERS; J H va de KAMER; W K DICKE; J IJSSELING
Journal:  Acta Paediatr       Date:  1961-01       Impact factor: 2.299

3.  Rapid method for the determination of fat in feces.

Authors:  J H VAN DE KAMER; H TEN BOKKEL HUININK; H A WEYERS
Journal:  J Biol Chem       Date:  1949-01       Impact factor: 5.157

4.  Reversible changes in duodenal mucosa associated with intensive chemotherapy followed by autologous marrow rescue.

Authors:  L Lubitz; H Ekert
Journal:  Lancet       Date:  1979-09-08       Impact factor: 79.321

Review 5.  Effects of cancer, radiotherapy and cytotoxic drugs on intestinal structure and function.

Authors:  M T Shaw; M H Spector; A J Ladman
Journal:  Cancer Treat Rev       Date:  1979-09       Impact factor: 12.111

6.  The contribution of the colon to electrolyte and water conservation in man.

Authors:  S F Phillips; J Giller
Journal:  J Lab Clin Med       Date:  1973-05

7.  Crypts are the site of intestinal fluid and electrolyte secretion.

Authors:  M J Welsh; P L Smith; M Fromm; R A Frizzell
Journal:  Science       Date:  1982-12-17       Impact factor: 47.728

8.  Effect of leukemia and methotrexate on digestive enzymes in the jejunum of mice.

Authors:  D Branski; E Lebenthal; A I Freeman; T F Hatch
Journal:  Digestion       Date:  1981       Impact factor: 3.216

9.  Enteral nutrition by nasogastric tube in adult patients treated with intensive chemotherapy for acute leukemia.

Authors:  E G de Vries; N H Mulder; B Houwen; H G de Vries-Hospers
Journal:  Am J Clin Nutr       Date:  1982-06       Impact factor: 7.045

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.